Depression and Cardiovascular Disease: The Viewpoint of Platelets

Area of Science:

• Cardiology
• Psychiatry
• Molecular Biology

Background:

• Depression is a significant cause of morbidity and reduced quality of life in cardiovascular disease (CVD) patients.
• Depression is an independent risk factor for major adverse cardiovascular events.
• A cross-vulnerability exists between depression and CVD, where each condition worsens the other's prognosis.

Purpose of the Study:

• To dissect the mechanisms linking depression and CVD.
• To highlight the critical role of platelet behavior during depression in triggering cardiovascular complications.
• To discuss the relationship between depression and CVD-related molecules impacting platelet activation.

Main Methods:

• Literature review focusing on the interplay between depression and CVD.
• Analysis of proposed mechanisms linking the two conditions.
• Emphasis on platelet activation as a key mediator.

Main Results:

• Platelet activation is a central mechanism in the depression-CVD interplay.
• Depression influences molecules (e.g., catecholamines, adipokines, lipids, ROS, chemokines) implicated in CVD.
• These molecules impact platelet activation, potentially triggering cardiovascular events.

Conclusions:

• Platelet behavior during depression is a critical factor in cardiovascular complications.
• Understanding the molecular mechanisms linking depression and CVD, particularly platelet activation, is crucial for improving patient outcomes.